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Abstract:  Fumonisins  are  mycotoxins  produced  by  Fusarium  verticillioides  and  
F. proliferatum, fungi that are ubiquitous in corn (maize). Insect damage and some other 
environmental conditions result in the accumulation of fumonisins in corn-based products 
worldwide. Current  methods  of  fumonisin  detection rely on the use of  immunoaffinity 
columns and high-performance liquid chromatography (HPLC). The use of aptamers offers 
a good alternative to the use of antibodies in fumonisin cleanup and detection due to lower 
costs  and  improved  stability.  Aptamers  are  single-stranded  oligonucleotides  that  are 
selected using Systematic Evolution of Ligands by EXponential enrichment (SELEX) for 
their ability to bind to targets with high affinity and specificity. Sequences obtained after 
18 rounds of SELEX were screened for their ability to bind to fumonisin B1. Six unique 
sequences were obtained, each showing improved binding to fumonisin B1 compared to 
controls. Sequence FB1 39 binds to fumonisin with a dissociation constant of 100 ±  30 nM 
and shows potential for use in fumonisin biosensors and solid phase extraction columns.  
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1. Introduction  
Molecular recognition plays an essential role in various biological and biomedical applications, 
particularly in biosensor development. In its simplest form, a biosensor consists of a specific molecular 
recognition probe targeting an analyte of interest and a means of converting that recognition event into 
a measurable signal. While antibodies have been the gold standard for molecular recognition elements 
for several decades, the relatively new technology of aptamers is emerging as a valuable molecular 
recognition tool. Aptamers are single stranded oligonucleotides that fold into distinct nanoscale shapes 
capable of binding to a target molecule. Aptamer-target recognition occurs through a combination of 
hydrogen  bonding,  electrostatic  interactions,  van  der  Waals  forces  and  stacking  interactions.  As 
molecular recognition probes, aptamers have binding affinities and specificities that are comparable to, 
and in some cases even surpass those of monoclonal antibodies. The ability of aptamers to fold into 
distinct 3-D conformations allows high affinity binding and selectivity for their target. For example, 
dissociation  constants  in  the  nanomolar  or  picomolar  range  have  been  achieved  with  aptamers. 
Furthermore, aptamers can discriminate targets on the basis of subtle structural differences such as 
chirality [1] or the presence or absence of a single methyl group [2]. Targets for which aptamers have 
been developed range from small molecules, such as nucleotides [3], to complex macromolecules, 
such as proteins [4] and even whole cells [5]. In certain applications, aptamer technology offers several 
advantages over antibodies. First, high-purity aptamers can be chemically synthesized at a low cost 
and can be easily modified with dyes and labels without affecting their affinities. Second, aptamers are 
more chemically stable under most environmental conditions, have a longer shelf life, and can be 
reversibly  denatured  without  loss  of  specificity.  These  properties  make  aptamers  attractive  in  the 
development of low-cost, robust diagnostics and biosensors [6].  
There is a growing need for rapid, inexpensive methods for the detection of contaminations in food 
and feed, both in the field and post-harvest. As molecular recognition is the cornerstone of sensing, 
there  has  been  increased  focus  on  the  development  of  new  molecular  recognition  probes  for  
food-safety related targets. Toxic fungal metabolites, known as mycotoxins, can contaminate a wide 
range of agricultural commodities, and are high priority targets for the development of new molecular 
recognition probes and biosensors. It is estimated that at least 25% of the grain produced worldwide is 
contaminated with mycotoxins [7]. However, even small concentrations of mycotoxins can induce 
significant health problems including vomiting, kidney disease, liver disease, cancer and death. Thus, 
aptamers displaying high affinity and selectivity for such toxins would be useful in the development of 
sensitive biosensing systems enabling simple and rapid detection. The development of aptamers for 
mycotoxins is of particular interest as the antibodies used for mycotoxin detection are susceptible to 
denaturation in the presence of solvents commonly used in their extraction [8]. An aptamer for the 
mycotoxin  ochratoxin  A  (OTA)  has  already  been  developed  and  integrated  into  several  detection 
systems  [9,10].  For  example,  the  OTA  aptamer  has  been  used  in  the  preparation  of  solid  phase Int. J. Mol. Sci. 2010, 11                       
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extraction  columns  for  OTA  clean-up  from  naturally  contaminated  wheat  samples  prior  to  liquid 
chromatographic (HPLC) analysis. Comparative analysis using traditional immunoaffinity clean-up 
procedures showed a good correlation between the two methods [11]. Additionally, the OTA aptamer 
has been incorporated into a colorimetric detection system utilizing gold nanoparticles, where accurate 
measurements  can  be  done  in  less  than  5  minutes  [12].  Aptamer-based  electrochemical  and 
electrochemiluminescent sensors have also been developed using the OTA aptamer. These systems are 
sensitive, displaying detection limits of 30 pg/mL and 7 pg/mL, respectively [13,14]. Other mycotoxin 
aptamers are also in development worldwide [15,16]. 
The mycotoxin Fumonisin B1 (FB1) is a nephrotoxin in all species tested, a carcinogen in rodents 
and a reproductive toxicant in rodents and likely in humans [17]. The Joint Expert Committee on Food 
Additives and Contaminants of the WHO established a Provisional Maximum Daily Intake which is 
being applied in different areas as a function of corn-based food consumption and exposures [18]. 
Unlike food-contaminating bacteria, FB1 is not inactivated by cooking temperatures, therefore careful 
monitoring of cereals is essential prior to distribution for consumption [19]. Given its toxicity and 
prevalence, several analytical methods have been reported for the detection of FB1. These include 
enzyme-linked  immunosorbent  assay,  capillary  zone  electrophoresis  and  high  performance  liquid 
chromatography technologies [20]. While these methods  are effective,  the need for highly trained 
personnel  and  expensive  equipment  make  them  inaccessible  in  all  but  the  most  well-equipped 
laboratories  as  well  as  impractical  for  rapid  testing  at  country  elevators,  for  example.  Thus,  a  
tight-binding  aptamer  for  FB1  could  be  an  important  tool  for  the  development  of  new  fumonisin  
clean-up and detection systems. 
Aptamers  are  discovered  using  an  in  vitro  process  called  Systematic  Evolution  of  Ligands  by 
EXponential  enrichment  (SELEX),  a  procedure  where  target-binding  oligonucleotides  are  selected 
from a random pool of sequences through iterative cycles of affinity separation and amplification  
(see Figure 1) [21,22]. The SELEX process begins with a large random oligonucleotide library (pool), 
whose complexity and diversity is dependent on the number of its random nucleotide positions [23].  
Figure 1. Schematic overview of the Systematic Evolution of Ligands by EXponential 
enrichment (SELEX) procedure. 
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During the SELEX procedure, separation of the binding DNA from the sequences lacking affinity is 
required. Typically, this is achieved by immobilizing the target of interest to a column matrix, usually 
agarose or sepharose,  allowing  easy  partitioning  of unwanted sequences through multiple washes. 
However, a more recent SELEX method termed FluMag SELEX makes use of magnetic beads as the 
solid matrix [24]. These beads can be surface-functionalized with almost any chemical group to allow 
for easy  covalent attachment of a target. Additionally, only a relatively small amount of target is 
required for efficient conjugation to the beads compared to conventional column materials.  
The next steps in SELEX include the elution of the binding sequences from the target and the 
polymerase  chain  reaction  (PCR)  amplification  of  those  binders  to  yield  an  enriched  pool  for 
subsequent, more stringent, selection rounds. As the interactions that lead to molecular recognition 
between the binding sequences and the target are non-covalent in nature, relatively mild conditions can 
be used to separate the two species. Elution is typically performed using high concentrations of the 
target  molecule,  high  temperatures  or  hydrogen-bond-disrupting  compounds  such  as  urea.  Once 
separated from the target, the few binding DNA sequences are amplified by PCR to yield a practical 
amount of sample to continue the process  
The enriched pool generated from this first round of selection is then subjected to further selection 
rounds  that  serve  to  increase  the  pool’s  affinity  for  the  target  molecule  (positive  selections)  or 
eliminate members of the pool that have affinity for undesirable compounds (negative selections). 
After several rounds, the enriched pool is cloned, sequenced, and characterized to find aptamers with 
the desired properties. Once these sequences are elucidated, solid-phase chemical synthesis is used to 
reproducibly  synthesize  aptamers  in  large  quantities.  During  aptamer  synthesis,  a  multitude  of 
chemical  modifications  are  possible,  such  as  end-labeling  for  covalent  attachment  or  backbone 
modification for increased stability, optimizing the aptamer’s properties for certain applications [25]. 
In this way, aptamers are ideal for many molecular recognition applications such as diagnostics and 
therapeutics. For example, aptamer-based biosensors have been developed for use in a variety of fields 
from medicine, to environmental monitoring and food safety [26,27].  
The production of an aptamer for FB1 is the first step in the realization of inexpensive, robust and 
innovative detection technology that could offer a solution to the limitations of the existing detection 
techniques. In turn, this testing process may be simple enough to be performed by crop handlers and 
agricultural inspectors in the field, ultimately reducing the exposure of the mycotoxin to animals and 
humans around the globe. This paper discusses the selection of FB1-binding aptamer sequences and an 
initial assessment of their binding affinity. 
2. Results and Discussion 
2.1. Fumonisin B1 Immobilization 
In order to easily separate binding DNA from non-binding DNA, immobilization of the target to a 
solid matrix is necessary. As magnetic separation technology is fast, simple and effective, the use of 
surface modified magnetic beads is a superior alternative to conventional immobilization on sepharose 
or agarose. In particular, substantially less target is required for efficient immobilization compared to 
the amounts required for column immobilization [28]. This is particularly important in the case of Int. J. Mol. Sci. 2010, 11                       
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expensive or rare targets such as FB1. Carboxylic acid modified beads were chosen due to the simple 
coupling chemistry possible with the sole primary amine of FB1. Fumonisin B2, B3 and B4 all have this 
amine, which could allow for a similar aptamer selection protocol for these other members of the 
fumonisin family in the future. In addition, some evidence has shown that the primary amine is a 
critical part of the anti-FB1 antibody binding epitope. Conjugation via the amine would likely force our 
aptamer  to  exclude  the  amine  in  its  binding  epitope,  which  could  allow  for  the  development  of 
antibody/aptamer sandwich assays [19].  
Successful conjugation of the target FB1, was confirmed using HPLC. O-phthaldialdehyde (OPA) 
derivatized  FB1  was  fluorescently  detected  at  a  retention  time  of  approximately  six  minutes. 
Quantification  of  unbound  FB1 using  a  standard  curve,  measured  as  the  total  peak  area,  showed  
1–5  nmol  of  target  successfully  conjugated  to  aliquots  of  5  ×  10
8  beads.  Comparison  of  the 
immobilized  FB1  in  the  presence  and  absence  of  the  required  coupling  agent,  
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC), showed that a small amount of 
FB1  (approximately  0.1  nmol)  can  non-specifically  interact  with  the  carboxylic  acid  surface  
activated beads.  
2.2. Selection of Aptamers 
Careful consideration was made when choosing the selection buffer for this experiment. Since the 
DNA  backbone  is  polyanionic,  the  negative–negative  charge  repulsion  may  inhibit  formation  of 
complex structures in the absence of counterions such as Na
+. This may ultimately impede binding 
with the target. Divalent cations in particular, such as Mg
2+, block the negative charge repulsion and 
allow  the backbone to  form  tighter folding.  Interestingly, aptamers  with  higher affinity show less 
magnesium dependence than weaker binding aptamers [29]. Therefore, performing SELEX under low 
magnesium  concentrations,  such  as  physiological  conditions  (1–2.5  mM  Mg
2+),  may  increase  the 
stringency of selection conditions, leading to the production of high-affinity binding aptamers. While 
the only other mycotoxin aptamer, the OTA aptamer, was selected under buffer conditions lacking 
calcium, an increase in binding affinity was observed upon the addition of calcium ions [9]. It is 
suggested that the OTA forms a coordination complex with divalent ions such as calcium with the aid 
of the carboxyl and hydroxyl groups. Calcium was included in the buffer for this experiment to allow 
for a similar coordination complex that may form between neighboring carboxyl groups in fumonisin. 
Many published aptamers fold into g-quadruplex structures such as the thrombin-binding aptamer [4], 
the DNA aptamer for hematoporphyrin [30] and the HIV-1 integrase aptamer [31]. Potassium was 
included in the selection buffer since monovalent cations, especially K
+, are required to help stabilize 
g-rich sequences into these guanosine tetrads.  
While aptamers have been selected using a variety of random  region  lengths  within the initial 
library, a 60 nucleotide length was chosen for these experiments. A minimum of 25 nucleotides should 
be employed to achieve a diversity of 10
15 different sequences. Generally, as the length of the random 
region increases, the structural complexity of the library increases. This increase in complexity allows 
for the presence of complex structures such as 4 and 5-way junctions, which are often high-affinity 
binders  [32].  For  this  reason,  lengths  over  200  nucleotides  have  been  used.  However,  practical 
limitations reduce the number of initial sequences that can actually be used for the first selection round Int. J. Mol. Sci. 2010, 11                       
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to 10 nmol or less. Therefore, as the length of the random region increases, sequence space becomes 
substantially under-sampled. An initial library with 60 random nucleotides was chosen to strike a 
balance between these two competing factors. 
When performing SELEX on a solid matrix for target immobilization, it is extremely important to 
ensure that any sequences displaying binding properties towards the matrix and/or the linker arm are 
eliminated. Once aptamers are generated, they are typically used to measure free target in solution, 
therefore  any  aptamer  affinity  derived  from  any  partial  binding  to  the  matrix  will  reduce  the 
functionality of the aptamer for sensing applications. For example, the published rhodamine aptamer 
displays  a  weaker  binding  to  the  target  rhodamine  when  in  solution  compared  to  when  it  is 
immobilized on the matrix used in the selection [33]. To mitigate this, it is necessary to remove all 
sequences  that  display  even  weak  binding  or  partial  recognition  to  the  matrix.  Typical  SELEX 
experiments do this by performing a pre-selection step prior to the first selection round to remove any 
initial sequences displaying this unwanted binding [34]. However, as mutation and evolution of the 
pool occurs with each selection and amplification step, we performed this negative selection prior to 
each round to ensure as much as possible that our pool was only binding to the target. To further 
enhance the selectivity of our aptamers, we performed our negative selection using various targets 
beginning  at  round 4.  These negative selection  steps, often  called  counter selections,  remove any 
sequences from the pool that bind to structurally similar molecules, or molecules that may be found in 
a  sample  containing  our  target  of  interest.  Jenison  et  al.  found  that  using  this  counter  selection 
technique  generated  an  aptamer  for  theophylline  that  displayed  a  10,000-fold  weaker  binding  to 
caffeine, two molecules which differ only by a single methyl  group [2]. Counter selections using  
L-homocysteine  (rounds  5–10),  L-cysteine  and  L-methionine  (rounds  11–15)  immobilized  to  the 
magnetic beads were used, since these amino acids could be easily coupled to the beads via the amino 
group.  Pool  sequences  that  only  bind  to  any  exposed  carboxylic  acid  functional  group  would  be 
removed  by  these  negative  selections.  Similarly,  in  the  last  three  rounds,  L-glutamic  acid  (round  
16–18) was then used as a counter selection to eliminate sequences with affinity for other similar 
carboxylic  acid  containing  molecules.  A  negative  selection  using  FB2  was  not  employed  in  our 
selections for several reasons. The difference between these two structures is very subtle: FB2 lacks the 
11-hydroxy group. While aptamers have been selected that can recognize as small a difference as this, 
the counter selection against FB2 would likely severely reduce the DNA pool and eliminate many high 
affinity binders. The loss of high affinity binders in order to gain selectivity may not be worthwhile in 
this case as  FB2 is often found in samples containing FB1. The European Commission maximum 
tolerable  intakes  include  the  total  of  FB1  and  FB2  intake;  therefore,  total  fumonisin  is  often  
detected [35]. Note that the absence of counter selections against FB2 does not guarantee that the 
selected aptamers will be able to bind both targets. 
To assess the enrichment of the library for target binding, as well as to determine when increased 
stringency could be applied to the selection, the percent binding of the DNA pool was monitored after 
each round using fluorescence and absorbance measurements (see Figure 2). Typical selection matrices 
include µmol amounts of target [36]. However, due to the cost and availability of the target FB1, as 
well as the possibility of using minute concentrations of target with the magnetic beads, our selection 
matrix contained a maximum of 5 nmol of target. In the later rounds, the amount of target available for Int. J. Mol. Sci. 2010, 11                       
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binding could be as low as 20 pmol (1:5 ratio of FB1:DNA). This accounts for the seemingly low 
percent recovery of binding sequences with each round.  
Figure 2. Percent recovery of binding ssDNA to the FB1 immobilized magnetic beads after 
each  selection  round.  With  any  observable  significant  increase  or  plateau  in  percent 
recovery,  increasingly  stringent  selection  conditions  were  implemented  the  following 
round (see Section 3 and Table 1). 
 
 
In the initial few rounds, the maximum amount of target immobilized beads (5 ×  10
8 beads) was 
used  for  selections.  This  was  to  ensure  complete  capture  of  binding  sequences.  However,  every  
4–5 rounds, the number of magnetic beads used for positive selection, and therefore the amount of 
target available for binding, was reduced 2- to 5-fold (see Table 1). This decrease in the concentration 
of  the  target  increased  the  stringency  of  the  selection  round,  allowing  for  competition  between 
sequences  within  the  selection.  Competition  for  the  fewer  binding  sites  should  ultimately  yield  
tighter-binding aptamers. Tok et al. described a novel method to generate DNA aptamers by using a 
single target-immobilized microbead. They found that the weak binding aptamers were displaced by 
the  higher  affinity  aptamers.  After  only  two  selection  cycles,  aptamers  displaying  dissociation 
constants in the low nanomolar range were obtained [37].  
Two other conditions were manipulated to increase the stringency of selections. First, non-binding 
aptamers were washed away with column buffer (prior to elution) only three times in the initial rounds. 
As the number of rounds increased, this was increased to eight washing steps to wash away not only 
the non-binding sequences but also any weaker-binding sequences. Second, the binding incubation 
time was slowly decreased as the selections progressed (see Table 1). In the initial rounds, a one hour 
period was used to allow for slow folding or refolding in the presence of the target. However, in the Int. J. Mol. Sci. 2010, 11                       
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last rounds, 20 minute incubations were used since higher affinity binding species can be readily 
selected within a short equilibration time [34]. 
Table 1. Summary of selection round conditions. 
Selection 
Round 
Negative Selection Used  Number of FB1 
derivatized beads 
used 
Incubation time with 
FB1 derivatized beads 
(min) 
1  Unmodified  5 ×  10
8  60 
2  Unmodified  5 ×  10
8  60 
3  Unmodified  5 ×  10
8  60 
4  Unmodified  5 ×  10
8  60 
5  L-homocysteine  1 ×  10
8  60 
6  L-homocysteine  1 ×  10
8  60 
7  L-homocysteine  1 ×  10
8  45 
8  L-homocysteine  1 ×  10
8  45 
9  L-homocysteine  1 ×  10
8  45 
10  L-homocysteine  5 ×  10
7  45 
11  L-cysteine and L-methionine  5 ×  10
7  45 
12  L-cysteine and L-methionine  5 ×  10
7  30 
13  L-cysteine and L-methionine  5 ×  10
7  30 
14  L-cysteine and L-methionine  5 ×  10
7  30 
15  L-cysteine and L-methionine  1 ×  10
7  30 
16  L-glutamic acid  1 ×  10
7  30 
17  L-glutamic acid  1 ×  10
7  30 
18  L-glutamic acid  1 ×  10
7  20 
Several methods are possible for the elution of target-binding sequences. Direct cleavage of the 
target-bound aptamer from the bead was not possible in this case. While elution by affinity with free 
ligand is typically the method of choice [34], the amount required for successful elution for each round 
(often up to 50 mM) of 98% purity would cost over $5,000. Typically, the target used for elution 
should  be  as  pure  as  possible:  this  would  cost  closer  to  $12,000  if  obtained  through  a  standard 
chemical supply house. For this reason, the elution methods available included changing the ionic 
strength or use of denaturants. We found that simply changing the ionic strength by the addition of 
metal chelators, such as (Ethylenedinitrilo)tetraacetic acid disodium salt (EDTA), or using deionized 
water, only allowed removal of weak binders. This is not surprising as some aptamers have been 
shown to maintain their binding in the absence of Na
+ and K
+ cations [9]. To fully remove the high 
affinity binders, several long elutions with 7 M urea at 90 °C  were required. However, to ensure our 
final aptamers would bind to FB1 free in solution, elution with pure FB1 was performed in the last two 
selection  rounds.  As  high  affinity  binders  in  these  late  rounds  of  SELEX  should  have  very  long 
residence times, a few long elution times were performed to completely remove all bound species. 
Following elution in these last two rounds, extensive clean-up to remove the FB1 from the binding 
sequences was required as the FB1 inhibited PCR and quenched fluorescence measurements.  
Six  unique  sequences  were  obtained  after  cloning  from  round  18  (see  Table  2).  Surprisingly, 
sequences having the highest incidence (FB1 31 and FB1 39) have the lowest G content. Typically, Int. J. Mol. Sci. 2010, 11                       
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aptamers are G rich, for example, the DNA aptamer for OTA (47% G) [9], the DNA aptamer for  
ATP  (45%)  [3],  the  DNA  cocaine  aptamer  (32%)  [38]  and  the  DNA  aptamer  for  
fibronectin (33%) [39].  
Table 2. Full length sequences obtained after selection round 18. 
Sequence 
5'-ATACCAGCTTATTCAATT-N
60-
AGATAGTAAGTGCAATCT-3'  
G Content 
(%) 
Sequence Incidence  
(% of Total) 
FB1 14  CTATACGGAGTGGATATCGATCTGTAACGT
GAGTGAGATAATGTGATGCATAGTCGTGG   
32   12.5  
FB1 16  CATCCAGTAACAAACACATAAGTAACGGC
GATATGTCAAAGCGGTATCGGCTACAGATG   
22   12.5  
FB1 23   GCGGATGCGTAAATGACGATAAACATAGAT
GGGGTATATCGCGATGCGACAGGGTGT  
35   12.5  
FB1 31   CGGGGACGTGTATACCAGCTTATTCAATTC
ACAGTTATGTCCTATACCAGCTTATTCAATT   
17  25  
FB1 32   AATGTACGATGTGTGGGCAACATGAGTATG
TCGTGTGATATCTAGATGAGGTAGCGGTGG  
37   12.5  
FB1 39   AATCGCATTACCTTATACCAGCTTATTCAAT
TACGTCTGCACATACCAGCTTATTCAATT  
8   25  
The  selected  sequences   were  folded  using  Mfold [40]  (see  Figure  3).  The  resulting  predicted 
secondary structures are all of very low complexity; all sequences are 1-way junction structures. While 
this is typical of several aptamers ( almost a quarter of all aptamers are 1 -way junctions [32]), some 
evidence has shown that higher complexity can lead to higher affinity  [41]. For this reason, attempts 
have  been  made  to  increase  the  structural  complexity  of  the  initial  libraries  used  in  SELEX , which 
would result in more complex aptamers [32]. At this early stage , however, it is unclear if the large, 
initially unstructured regions of these sequences are involved in target binding, nor is it known whether 
these stretches fold in the presence of the target molecule as a result of new molecular interactions.  
These questions will be addressed in our future work. 
2.3. Binding Assays 
Each aptamer clone was tested for its ability to bind to FB1 derivatized beads using a fluorescence 
binding  assay.  This  allowed  for  comparative  determination  of  the  relative  binding  ability  of  each 
aptamer  generated  in  the  selection  experiment.  The  selection  conditions  used  in  the  SELEX 
experiment were used for these binding assays, using aliquots of FB1 derivatized beads as the target. 
To remove any non-binding or weakly-bound DNA, many washes were performed. Bound DNA was 
eluted first with column buffer at 90 ° C. Elution using high temperatures is sufficient to denature most 
target-DNA interactions; however, the addition of the denaturant urea, in our experience, is able to 
displace even the strongest, non-covalent, interaction. The comparison of binding DNA eluted only 
with 90 ° C buffer compared to 90 ° C urea can be found in Figure 4. The specific binding of the 
aptamers  to  the  target  was  compared  to  binding  of  the  unenriched  initial  library  (Control  Pool). 
Binding assays were also performed on unmodified (control) magnetic beads. This was done to ensure Int. J. Mol. Sci. 2010, 11                       
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that the individual clones were binding specifically to FB1 and not simply non-specifically interacting 
with the surface of the magnetic beads. 
Figure 3. Secondary structure prediction for the full length clones. Image generated by Mfold. 
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Figure 4. Binding assays of the individual aptamer sequences against FB1 beads compared 
to the unmodified beads (labeled as control beads). The percent of DNA eluted with buffer 
at 90 °C  is in blue, the DNA eluted using 7 M urea at 90 °C  is in grey. The unenriched 
(Control Pool) was tested on the FB1 modified beads as a comparison. 
 
Control pool, before any enrichment, has a small degree of non-specific affinity for the beads, as 
evidenced  by  the  low  percentage  of  DNA  bound.  This  amount  is  comparable  to  the  non-specific 
binding seen between each of the sequences and the unmodified beads (Control Beads). For most 
sequences, 50% or more of the DNA non-specifically bound to the unmodified beads can be removed 
using the 90 °C  buffer, indicative that these interactions are relatively weak. The opposite is true in the 
case of the aptamer sequences and their affinity for FB1 beads. Across all sequences, a 2- to 5-times 
increase in affinity is seen in the presence of the target, and all required high concentrations of 90 °C  
urea in order to remove the majority of the bound sequences. The observed percent binding of the 
aptamer  sequences  is  sizeable  for  this  type  of  assay.  A  similar  binding  assay  performed  using 
streptavidin conjugated magnetic beads by Stoltenburg et al. showed a maximum percent binding of 
21% for their aptamer clones. Despite their lower binding percents observed, their aptamers  were 
found to bind to the target with dissociation constants in the low nanomolar range [24]. 
Interestingly, FB1 39, which yielded the highest binding to the target, contains the lowest guanosine 
content (only 8%). As mentioned earlier, this is atypical of most aptamers. This sequence is slightly T 
enriched (35%) compared to C (27%) or A (30%). While less common, there is some precedent for  
T-rich aptamer sequences. For example, the DNA aptamer for tubulin is a T-rich aptamer displaying 
binding in the micromolar range. The random library used in their selection was also able to generate Int. J. Mol. Sci. 2010, 11                       
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G-rich aptamers for other targets such as chitin, indicating that the T-rich aptamer property is specific 
for the target type and not simply a chance event due to the nature of the original pool [42]. 
The binding affinity of sequence FB1 39 was investigated in more detail and was found to interact 
with immobilized FB1 with a dissociation constant, KD, of 100 ±  30 nM (see Figure 5). Therefore, this 
full length aptamer clone displays a high affinity for this relatively small molecular target. Comparable 
binding of the aptamer to the target when in solution is expected and will be determined in our future 
work. Further analysis will also attempt to identify the minimal target-binding sequence to shorten the 
aptamer and improve binding while lowering the aptamer’s production cost. 
Figure 5. Binding curves for the aptamer sequence FB1 39. Three trials were performed to 
obtain  saturation  curves  used  to  determine  the  dissociation  constant  (KD).  Bound 
fluorescein-labeled aptamer was measured by fluorescence (excitation at 490 nm, emission 
at 518 nm).  
 
As with the OTA aptamer, the effect of binding in an increased concentration of calcium will also 
be studied. The initial full length aptamer for OTA displayed a KD of 360 nM. After identifying the 
minimal binding sequence and adding calcium to the binding buffer, the OTA aptamer displayed a KD 
as  low  as  54  nM.  A  similar  situation  may  be  expected  with  our  FB1  39  sequence.  Therefore, 
dissociation constants for the final minimal aptamer will be determined and cross-reactivity tests will 
be run against other mycotoxins such as fumonisin B2. Stability of the aptamer under typical fumonisin 
extraction  conditions  and  the  feasibility  of  incorporating  the  aptamer  into  solid  phase  extraction 
columns and biosensor systems will be examined.  
3. Experimental Section 
3.1. Reagents 
DNA synthesis reagents were purchased from Glen Research (Sterling, VA, U.S.). Magnetic beads 
were purchased from Bangs Laboratories Inc. (Fishers, IL, U.S.). Fumonisin B1 was produced and 
purified in our laboratory according to Miller et al. [43]. All PCR and electrophoresis components Int. J. Mol. Sci. 2010, 11                       
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were purchased from BioShop Canada Inc. (Burlington, ON, Canada). Chemicals for buffer solutions 
and all other purposes were purchased from Sigma-Aldrich (Oakville, ON, Canada). 
3.2. Derivatization of Magnetic Beads 
ProMag 3 Series Carboxylic acid Surfactant Free Bangs magnetic beads were covalently modified 
with  fumonisin  B1  through  its  primary  amine  according  to  the  instructions  from  the  beads 
manufacturer. Aliquots of 500 µL (approximately 5 ×  10
8 beads) were washed several times with 
Coupling Buffer (0.1 M K2HPO4, 0.15 M NaCl (pH 5.5)) and the beads were magnetically separated 
from the supernatant using a Dynal MPC-S, 6 ×  1.5mL tube magnet. 500 µL of a 0.05 mM FB1 
solution  was  reacted  with  the  beads  both  in  the  presence  and  absence  of  excess  
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide  (EDC) hydrochloride (~5 mM) for 60 minutes. To 
determine successful immobilization, unbound FB1 remaining in the supernatant was measured using 
HPLC  with  fluorescence  detection  after  derivatization  with  OPA  reagent  as  described  by  
Visconti et al. [44]. Separation was achieved with a C18 reverse phase HPLC column (5 µm , 250 ×  4.6 mm) 
using a methanol: 0.1 M NaH2PO4 (77:23 v/v, pH 3.35) solvent system. Bound FB1 was calculated as 
the difference between the initial and unbound concentrations in the supernatants. Separate aliquots of 
beads were derivatized with one of L-homocysteine, L-cysteine, L-methionine or L-glutamic acid for 
counter selection steps. 
3.3. DNA Library and Primer Synthesis 
The starting DNA library was synthesized on a 1 µmol scale on a MerMade 6 Oligonucleotide 
synthesizer  (BioAutomation  Corporation,  USA)  using  standard  phosphoramidite  chemistry.  The 
sequence is 96 nucleotides in length, containing a central region of 60 random nucleotides flanked by 
two  primer  binding  sites  necessary  for  PCR  and  cloning:  5'-ATACCAGCTTATTCAATT-N60-
AGATAGTAAGTGCAATCT-3'. The following primers used for amplification and cloning of the 
selected oligonucleotides were synthesized: Primer1: 5'- ATACCAGCTTATTCAATT-3' and Primer2: 
5'-AGATTGCACTTACTATCT-3'. Modified primers were also synthesized to allow for fluorescent 
labeling of the binding DNA and separation of strands on a denaturing polyacrylamide gel: ModPrimer 
1:  5'-fluorescein-ATACCAGCTTATTCAATT-3'  and  ModPrimer  2  5'-poly-dA20-HEG-
AGATTGCACTTACTATCT-3'.  All  synthesized  DNA  was  purified  through  denaturing 
polyacrylamide  gel  electrophoresis  (12%)  followed  by  clean-up  with  Amicon  YM-3  Centrifugal  
Filter Devices. 
3.4. SELEX Experiments  
Fresh aliquots of FB1 derivatized beads and unmodified beads or beads modified with a counter 
selection target were washed 5-times with 0.5 mL of Column Buffer (100 mM NaCl, 20 mM Tris,  
2 mM MgCl2, 5 mM KCl, 1 mM CaCl2, pH 7.6) before each SELEX round. Prior to the first selection, 
the pool (2 nmol) was suspended in 0.5 mL of column buffer and heated for 10 minutes at 90 °C  then 
cooled at 4 °C  for 15 minutes, followed by incubation at room temperature for at least 7 minutes. In 
subsequent rounds, 100 pmol of pool was used. The pool was first incubated with either unmodified Int. J. Mol. Sci. 2010, 11                       
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beads or beads derivatized with counter selection target molecules with mild shaking for 60 minutes. 
Only DNA lacking affinity for the unmodified beads or counter selection targets was collected by 
removal of the bead supernatant. This pool, devoid of sequences displaying non-specific affinity, was 
subjected to the same heating and cooling process described above, followed by incubation with a 
varying  amount  of  FB1  derivatized  beads  and  for  a  specific  amount  of  time,  depending  on  the 
stringency of binding selection desired (see Table 1). Following incubation, sequences with little to no 
affinity for FB1 were removed by washing 3–8 times with 0.1 mL of Column Buffer. DNA bound to 
the FB1 was then removed with 7 M urea at 90 °C . Five elution fractions of 0.1 mL each, were 
collected,  purified  using  Amicon  Ultra  3  KDa  0.5  mL  centrifugal  filters  and  quantified  using  
UV-visible spectroscopy and/or fluorescence. In the final two selection rounds, binding DNA was 
removed with five 30 minute elutions using 0.2 mM FB1.  
The entire selected oligonucleotide pool was amplified in 15–30 parallel PCR reactions for the first 
round, in subsequent rounds only 90% of the selected pool was amplified with the remaining 10% set 
aside for analysis and in case of PCR failure. Each reaction consisted of 0.1 M Tris HCl pH 9, 50 mM 
KCl, 1% Triton X-100, 2.0 mM MgCl2, 0.2 mM dNTP mix, 1 μM each modified primer and 5 units of 
Taq DNA polymerase. The DNA was initially melted for 10 minutes at 94 °C , followed by 25 cycles 
of  94  °C   (1  min),  47  °C   (1  min)  and  72  °C   (1  min).  Final  extension  occurred  at  72  °C   for  
10 minutes after the last cycle. In rounds 10–18, asymmetric PCR (1:50 ratio of primers, 35 cycles) 
was performed to facilitate the isolation of the aptamer strand from the complement. PCR products 
were dried down, heated at 55 °C  for 5 minutes in the presence of formamide and run through a 12% 
denaturing PAGE to separate the double stranded product. The fluorescein labeled DNA strand (the 
selected sequences) could be identified using an Alpha Imager UV-illuminator. The corresponding 
DNA bands were cut from the gel and extracted using the freeze/rapid thaw method described by Chen 
and Ruffner [45] in 10 mM Tris HCl buffer, pH 7.4. The DNA was then purified using the Amicon 
centrifugal  filters,  quantified  and  re-suspended  in  column  buffer  and  could  be  used  in  the  next 
selection round. 
Enrichment of the DNA pool was assessed throughout the rounds of selection by monitoring the 
percent  of  DNA  pool  binding  to  the  FB1  derivatized  beads  using  UV-vis  and  fluorescence 
measurements. After round 16, no additional enrichment was observed; therefore a total of 18 selection 
rounds were performed. 
3.5. Cloning and Sequencing 
The enriched DNA pool obtained from SELEX round 18 was PCR amplified using the unmodified 
primers (Primer 1 and 2) and cloned using the StrataClone PCR Cloning Kit (Agilent Technologies, 
Mississauga, ON, Canada). Positive colonies (white) were picked and a small portion of the plaque 
was  removed  carefully  and  transferred  to  the  Templiphi  sample  buffer.  DNA  was  prepared  for 
sequencing  by  rolling-circle  amplification  using  the  TempliPhi  Amplification  kit  (GE  Healthcare, 
Canada). These samples were sent for full service sequencing at the University of Calgary University 
Core DNA Services (AB, Canada). The 6 unique sequences were tested for binding to FB1.  Int. J. Mol. Sci. 2010, 11                       
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3.6. Binding Assays 
The fluorescein-labeled (6-FAM) sequences to be tested (6 unique sequences obtained from the 
cloning experiment and some unenriched pool prior to SELEX) were synthesized on a 1 µmol scale 
using standard phosphoramidite chemistry. Sequence synthesis was verified through molecular weight 
verification using electrospray ionization (ESI) mass spectrometry (Novatia LLC, Monmouth Junction, 
NJ, USA). Each sequence was heated to 90 °C  for 10 minutes, cooled to 4 °C  and incubated at room 
temperature for 7 minutes. Aliquots of 2 ×  10
8 FB1 derivatized beads were washed with column buffer 
and  incubated  for  30  minutes  at  room  temperature  with  9  to  15  pmol  of  each  DNA  sequence 
separately. Non-binding DNA was removed with several washing steps using column buffer. Bound 
DNA was eluted first with two 0.1 mL fractions of column buffer at 90 °C  for 10 minutes each. To 
ensure complete removal of bound DNA, elution using two fractions of 0.1 mL 7 M urea at 90 °C  for  
10  minutes  was  also  performed.  The  percent  of  DNA  eluted  with  column  buffer  and  urea  were 
determined  using  fluorescence  (excitation  at  490  nm,  emission  at  518  nm)  and  calculation  using 
calibration curves. The same experiment was performed on unmodified beads to ensure the observed 
binding of sequences was specific to the target. 
3.7. Determination of the Dissociation Constant 
The  dissociation  constant  was  obtained  for  aptamer  sequence  FB1  39.  Binding  assays  were 
performed as above, by exposing varying concentrations of aptamer (1 nM to 1 µM) to 2 ×  10
8 FB1 
derivatized beads in column buffer. Non-binding DNA was removed by washing five times. Bound 
DNA was eluted with two 0.1 mL fractions of column buffer at 90 °C  for 10 minutes each. The 
fluorescence of the eluted aptamer was recorded and the dissociation constants were evaluated by 
minimizing  the  residual  values  between  calculated  and  observed  experimental  ∆fluorescence  data 
using the solver feature of Microsoft Excel [46]. This experiment was performed three times to obtain 
the reported dissociation constant. 
4. Conclusions 
Eighteen rounds of increasingly stringent selection conditions were performed in order to obtain 
DNA sequences displaying high binding affinity to fumonisin B1. Of the six individual sequences 
obtained from  the  SELEX experiment, several candidates  displayed superior binding to  the target 
compared to controls. Aptamer sequence FB1 39, displaying low complexity and an unexpectedly low 
percent  of  G,  displayed  the  highest  percent  binding  to  the  target.  This  sequence,  displaying  a 
dissociation constant in the nanomolar range, will be further processed to optimize the length and 
binding affinity to fumonisin. This aptamer is a promising tool for use in fumonisin clean-up and 
detection systems to efficiently detect low levels of fumonisin in food commodities. This aptamer may 
allow the development of a testing process simple enough to be performed by maize handlers and 
agricultural inspectors in the field and greatly reduce the exposure of animals and humans to FB1.  Int. J. Mol. Sci. 2010, 11                       
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